Pharmacy Focus: Oncology Edition - PARP Inhibitors in Ovarian Cancer

Kirollos Hanna, PharmD, BCPS, BCOP, discussed how PARP inhibitors have changed the treatment landscape of ovarian cancer.

In the second episode of Pharmacy Focus: Oncology Edition, Kirollos Hanna, PharmD, BCPS, BCOP, discussed how PARP inhibitors have changed the treatment landscape of ovarian cancer.

Related Videos
Patient with cancer receiving an infusion | Image credit: RFBSIP - stock.adobe.com
Burnout illustration | Image credit: Vikky Mir - stock.adobe.com
Stack of files and gavel | Image credit: BillionPhotos.com - stock.adobe.com
Cancer patient with IV | Image credit: Monkey Business - stock.adobe.com
Capitol Building | Image credit: lazyllama - stock.adobe.com
Related Content

Opioid Tapering in Cancer Survivors

March 31st 2023

Pharmacy Focus: Public Health Matters - What is Public Health?

March 30th 2023

Predicting Chemotherapy Benefit in Patients With Breast Cancer With Positive Lymph Nodes Who Are Postmenopausal, Premenopausal

March 31st 2023

Pharmacy Focus: Psychedelic Pharmacy - Psychedelics Are Changing the Landscape of Mental Health

March 24th 2023

5 Key Sessions, Interviews at HOPA Annual Conference 2023

March 29th 2023

Pembrolizumab Improves Progression-Free Survival in Endometrial Carcinoma

March 29th 2023

Opioid Tapering in Cancer Survivors

March 31st 2023

Pharmacy Focus: Public Health Matters - What is Public Health?

March 30th 2023

Predicting Chemotherapy Benefit in Patients With Breast Cancer With Positive Lymph Nodes Who Are Postmenopausal, Premenopausal

March 31st 2023

Pharmacy Focus: Psychedelic Pharmacy - Psychedelics Are Changing the Landscape of Mental Health

March 24th 2023

5 Key Sessions, Interviews at HOPA Annual Conference 2023

March 29th 2023

Pembrolizumab Improves Progression-Free Survival in Endometrial Carcinoma

March 29th 2023

Opioid Tapering in Cancer Survivors

March 31st 2023

Pharmacy Focus: Public Health Matters - What is Public Health?

March 30th 2023

Predicting Chemotherapy Benefit in Patients With Breast Cancer With Positive Lymph Nodes Who Are Postmenopausal, Premenopausal

March 31st 2023

Pharmacy Focus: Psychedelic Pharmacy - Psychedelics Are Changing the Landscape of Mental Health

March 24th 2023

5 Key Sessions, Interviews at HOPA Annual Conference 2023

March 29th 2023

Pembrolizumab Improves Progression-Free Survival in Endometrial Carcinoma

March 29th 2023
© 2023 MJH Life Sciences

All rights reserved.